Articular manifestations related to anti-interleukin-5 therapies in severe asthma: a case series.

IF 4.3 3区 医学 Q1 RESPIRATORY SYSTEM
ERJ Open Research Pub Date : 2024-02-26 eCollection Date: 2024-01-01 DOI:10.1183/23120541.00935-2023
Clairelyne Dupin, Solène Valéry, Laurent Guilleminault, Gilles Devouassoux, Marine Merveilleau, Maud Russier, Gisèle Mourin, Johana Pradelli, Philippe Bonniaud, Mathilde Le Brun, Esther Ebstein, Pierre-Antoine Juge, Agnès Lillo-Lelouet, Camille Taillé
{"title":"Articular manifestations related to anti-interleukin-5 therapies in severe asthma: a case series.","authors":"Clairelyne Dupin, Solène Valéry, Laurent Guilleminault, Gilles Devouassoux, Marine Merveilleau, Maud Russier, Gisèle Mourin, Johana Pradelli, Philippe Bonniaud, Mathilde Le Brun, Esther Ebstein, Pierre-Antoine Juge, Agnès Lillo-Lelouet, Camille Taillé","doi":"10.1183/23120541.00935-2023","DOIUrl":null,"url":null,"abstract":"<p><p><b>Articular manifestations should be screened before and during anti-IL-5/5R biologic treatment in severe asthma. Rigorous multidisciplinary team discussion should be carried out to assess the risk-benefit balance of withholding effective treatment.</b> https://bit.ly/3vfPn4k.</p>","PeriodicalId":11739,"journal":{"name":"ERJ Open Research","volume":"10 1","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2024-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10895420/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ERJ Open Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1183/23120541.00935-2023","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Articular manifestations should be screened before and during anti-IL-5/5R biologic treatment in severe asthma. Rigorous multidisciplinary team discussion should be carried out to assess the risk-benefit balance of withholding effective treatment. https://bit.ly/3vfPn4k.

严重哮喘患者与抗白细胞介素-5疗法相关的关节表现:病例系列。
在对重症哮喘患者进行抗IL-5/5R生物制剂治疗之前和治疗期间,应筛查关节表现。应进行严格的多学科团队讨论,以评估暂停有效治疗的风险与收益平衡。https://bit.ly/3vfPn4k。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ERJ Open Research
ERJ Open Research Medicine-Pulmonary and Respiratory Medicine
CiteScore
6.20
自引率
4.30%
发文量
273
审稿时长
8 weeks
期刊介绍: ERJ Open Research is a fully open access original research journal, published online by the European Respiratory Society. The journal aims to publish high-quality work in all fields of respiratory science and medicine, covering basic science, clinical translational science and clinical medicine. The journal was created to help fulfil the ERS objective to disseminate scientific and educational material to its members and to the medical community, but also to provide researchers with an affordable open access specialty journal in which to publish their work.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信